Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis. (Q39165264)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Bruce Mann

series ordinal

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Steven A Stacker

series ordinal

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

7

Rae H Farnsworth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

2

Sally Roufail

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

5

Tara Karnezis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

6

Ramin Shayan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

4

Carol Caesar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

8

Teruhiko Sato

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

3

Rachael Inder

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1

Masataka Matsumoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

1 reference

17 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

819-832

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23591595%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10585-013-9581-x

28 February 2020

exact match

0 references

cites work

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

VEGF and the quest for tumour angiogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Vascular endothelial growth factor-D: signaling mechanisms, biology, and clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Lymphatic vessels in cancer metastasis: bridging the gaps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Lymphangiogenic growth factors as markers of tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Focus on lymphangiogenesis in tumor metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Targeting lymphangiogenesis to prevent tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Molecular control of lymphatic metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9581-X

VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme

21 January 2018

1 reference

12 December 2020

Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody

1 reference

12 December 2020

Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer

1 reference

12 December 2020

A potential role for vascular endothelial growth factor-D as an autocrine growth factor for human breast carcinoma cells

1 reference

12 December 2020

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

12 December 2020

Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma

1 reference

12 December 2020

A system for quantifying the patterning of the lymphatic vasculature

1 reference

12 December 2020

Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma

1 reference

12 December 2020